Life Sciences

Antibody drug conjugates and other bioconjugates for the treatment and diagnosis of disease. Also includes click chemistry and other novel biochemical methods for conjugation.

Software tools that assist in critical decision making tasks that physicians and clinical administrators encounter everyday

Technologies that use artificial intelligence to drastically increase the value of medical images collected using ultrasound, PET, CT, MRI, and other common medical imaging modalities.

This collection contains technologies targeting cardiac dysfunction, diabetes, stroke, obesity, and fatty liver disease, including small molecule inhibitors, drug delivery systems, cell therapies, gene editing tools, and diagnostic methods.

Tools to help treat neurodegenerative diseases, including novel targets against conditions like Huntington’s diseases, Alzheimer’s, and Parkinson’s.

Technologies to help diagnose and treat psychiatric conditions like PTSD & depression.

Technologies for the diagnosis and treatment of skin pathologies such as psoriasis, scarring, wounds, and more. Also includes novel approaches in digital health and medtech for dermatological applications.

Selected diagnostic and prognostic technologies spanning liquid biopsy, molecular profiling, imaging and immunoassays for applications in cancer and other diseases.

Technologies to accelerate your therapeutic pipeline ranging from in vitro high throughput screening platforms to artificial intelligence in silico screening platforms

This collection features Stanford-developed drug delivery and design technologies, including hydrogels, exosomes, nanoparticles, and targeted delivery systems, aimed at improving therapeutic efficacy and lowering toxicity.

Inventions enabling the next generation of gene therapy, including nucleic acid editing and delivery systems.

Technologies to increase the applicability and effectiveness of adoptive T-cell and NK cell therapies, reduce T-cell exhaustion, improve safety, and novel targets

New targets, state-of-the-art delivery systems, and novel large and small molecule drugs that offer next-generation approaches to harness the immune system to fight cancer

Browse cell and gene therapies, diagnostics, and small molecule therapies targeting autoimmune and inflammatory diseases.

This intellectual property portfolio includes vaccine development platforms, antibiotics, antivirals, and diagnostic tools targeting infectious diseases, including COVID-19.

Technological solutions to help enable the next generation of advanced neurological treatment devices.

Ophthalmology technologies from Stanford inventors

Optogenetics technologies with multifaceted applications in drug discovery, therapeutics, neurostimulation, neurodegenerative diseases, mood disorders, and neuroimaging.

Technologies for creation and use of organoids & assembloids

See a collection of available Stanford technologies for the treatment of rare diseases like IPEX, Duchenne's muscular dystrophy, Friedreich's Ataxia, polycythemia, and more. Includes both cell & gene therapies and small molecule & antibody therapies

Molecular, cellular, and antibody tools and methods, DNA sequencing & analysis technologies, optical biosensing and analytics technologies, etc.

RNA technologies for designing treatments for human disease

Women's Health-related technologies from Stanford inventors.